We are live on ! Find out more
EVM

Eaton Vance Management Portfolio holdings

AUM $67.5B
1-Year Est. Return 11.44%
This Fund
S&P 500
This Quarter Est. Return
-12.97%
1 Year Est. Return
-11.44%
3 Year Est. Return
+49.6%
5 Year Est. Return
+94.25%
10 Year Est. Return
AUM
$38.5B
AUM Growth
-$6.57B
Cap. Flow
-$145M
Cap. Flow %
-0.38%
Top 10 Hldgs %
21.3%
Holding
1,250
New
56
Increased
461
Reduced
378
Closed
80

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$105M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$86.8M
3
XOM icon
ExxonMobil
XOM
+$84.8M
4
PFE icon
Pfizer
PFE
+$82.8M
5
CSX icon
CSX Corp
CSX
+$63.6M

Sector Composition

Rank Sector Weight
1 Technology 16.78%
2 Healthcare 16.5%
3 Financials 15.73%
4 Consumer Discretionary 11.3%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
76
Boston Scientific
BSX
$68.4B
$134M 0.35%
3,804,913
-1,530,062
-29% -$55.5M
RTN
77
DELISTED
Raytheon Company
RTN
$134M 0.35%
876,414
+299,747
+52% +$53.7M
FDX icon
78
FedEx
FDX
$73B
$130M 0.34%
808,694
-18,853
-2% -$3.99M
BMY icon
79
Bristol-Myers Squibb
BMY
$129B
$130M 0.34%
2,509,794
-321,202
-11% -$17.3M
WMT icon
80
Walmart Inc
WMT
$909B
$125M 0.33%
4,028,814
+26,223
+0.7% +$841K
PH icon
81
Parker-Hannifin
PH
$120B
$125M 0.32%
835,864
-114,049
-12% -$18.5M
C icon
82
Citigroup
C
$213B
$124M 0.32%
2,390,613
-243,022
-9% -$15.4M
ISRG icon
83
Intuitive Surgical
ISRG
$127B
$124M 0.32%
776,535
+230,250
+42% +$39M
CVS icon
84
CVS Health
CVS
$135B
$120M 0.31%
1,835,107
+66,038
+4% +$4.93M
GS icon
85
Goldman Sachs
GS
$289B
$119M 0.31%
712,316
-216,322
-23% -$43.6M
TMO icon
86
Thermo Fisher Scientific
TMO
$214B
$116M 0.3%
519,357
+32,557
+7% +$7.64M
ATVI
87
DELISTED
Activision Blizzard
ATVI
$116M 0.3%
2,481,686
+602,299
+32% +$36.1M
SPGI icon
88
S&P Global
SPGI
$124B
$115M 0.3%
678,085
+102,097
+18% +$18.3M
HAL icon
89
Halliburton
HAL
$26.1B
$114M 0.3%
4,292,868
+688,452
+19% +$23.2M
MS icon
90
Morgan Stanley
MS
$319B
$112M 0.29%
2,829,403
+58,643
+2% +$2.56M
CL icon
91
Colgate-Palmolive
CL
$74.8B
$111M 0.29%
1,872,215
-766,322
-29% -$47.9M
GLW icon
92
Corning
GLW
$107B
$111M 0.29%
3,675,217
-8,050
-0.2% -$257K
BIIB icon
93
Biogen
BIIB
$30.9B
$111M 0.29%
367,532
-81,109
-18% -$25.9M
CSX icon
94
CSX Corp
CSX
$94B
$109M 0.28%
5,260,731
-2,763,546
-34% -$63.6M
CB icon
95
Chubb
CB
$140B
$108M 0.28%
832,417
+76,122
+10% +$9.84M
UNP icon
96
Union Pacific
UNP
$174B
$106M 0.28%
766,888
+6,442
+0.8% +$954K
HXL icon
97
Hexcel
HXL
$7.97B
$104M 0.27%
1,812,729
+307,192
+20% +$18.5M
KEY icon
98
KeyCorp
KEY
$23.8B
$104M 0.27%
7,026,511
-2,637,441
-27% -$46.4M
MDT icon
99
Medtronic
MDT
$112B
$104M 0.27%
1,140,570
+11,165
+1% +$1.04M
FTV icon
100
Fortive
FTV
$18B
$103M 0.27%
2,405,978
-148,431
-6% -$6.97M

Similar funds

Eaton Vance Management's Q4 2018 Portfolio in Review

As of Q4 2018, Eaton Vance Management held 1,250 positions worth $38.5B, down 15% from $45.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Eaton Vance Management's Q4 2018 filing shows 56 new, 461 increased, 378 reduced and 80 closed positions. Its largest new stake was DocuSign: 656,210 shares worth $26.3M. The largest sale was Aetna Inc, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Eaton Vance Management's largest Q4 2018 buy was DocuSign: 656,210 shares worth $26.3M.
  • Eaton Vance Management added most to Procter & Gamble in Q4 2018, an estimated $143M increase.
  • Eaton Vance Management's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $86.8M.
  • Eaton Vance Management fully exited Aetna Inc in Q4 2018, selling an estimated $105M.
  • Eaton Vance Management's ten largest holdings make up 21% of its $38.5B portfolio in Q4 2018.
  • Eaton Vance Management opened 56 new positions and closed 80 in Q4 2018.
  • Eaton Vance Management's portfolio value fell 15% quarter-over-quarter to $38.5B.

Based on Eaton Vance Management's 13F filing for Q4 2018, filed 7 Feb 2019.